
The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …
NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …

Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …
European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …
A new training resource aimed at helping primary care nurses manage asthma has been launched with funding from Merck Sharp …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

